The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
R Cunningham, CG Hansen - Clinical Science, 2022 - portlandpress.com
Tumorigenesis is a highly complex process, involving many interrelated and cross-acting
signalling pathways. One such pathway that has garnered much attention in the field of …
signalling pathways. One such pathway that has garnered much attention in the field of …
Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit
Adaptions to therapeutic pressures exerted on cancer cells enable malignant progression of
the tumor, culminating in escape from programmed cell death and development of resistant …
the tumor, culminating in escape from programmed cell death and development of resistant …
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance
A Chakravarthy, I Reddin, S Henderson, C Dong… - Nature …, 2022 - nature.com
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer
deaths in women. Here we present an integrated multi-omic analysis of 643 cervical …
deaths in women. Here we present an integrated multi-omic analysis of 643 cervical …
[HTML][HTML] Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma
T Zhang, B Sun, C Zhong, K Xu, Z Wang… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Background Intrinsic or acquired resistance to epidermal growth factor receptor-tyrosine
kinase inhibitors (EGFR-TKIs) is common, thus strategies for the management of EGFR-TKIs …
kinase inhibitors (EGFR-TKIs) is common, thus strategies for the management of EGFR-TKIs …
[HTML][HTML] Gene therapy for diffuse pleural mesotheliomas in preclinical models by concurrent expression of NF2 and SuperHippo
Diffuse pleural mesothelioma (DPM) is a lethal cancer with a poor prognosis and limited
treatment options. The Hippo signaling pathway genes, such as NF2 and LATS1/2, are …
treatment options. The Hippo signaling pathway genes, such as NF2 and LATS1/2, are …
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
RR Kowash, EA Akbay - Frontiers in immunology, 2023 - frontiersin.org
The adenosine pathway is an exciting new target in the field of cancer immunotherapy.
CD73 is the main producer of extracellular adenosine. Non-small cell lung cancer (NSCLC) …
CD73 is the main producer of extracellular adenosine. Non-small cell lung cancer (NSCLC) …
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a lethal malignancy etiologically caused by
asbestos exposure, for which there are few effective treatment options. Although asbestos …
asbestos exposure, for which there are few effective treatment options. Although asbestos …
Molecular alterations in malignant pleural mesothelioma: A hope for effective treatment by targeting YAP
Malignant pleural mesothelioma is a rare and aggressive neoplasm, which has primarily
been attributed to the exposure to asbestos fibers (83% of cases); yet, despite a ban of using …
been attributed to the exposure to asbestos fibers (83% of cases); yet, despite a ban of using …
Mesothelioma malignancy and the microenvironment: molecular mechanisms
Simple Summary In the tumor microenvironment, interaction among tumor cells, immune
cells, stromal cells, and the extracellular matrix is vital to support pro-tumor mechanisms …
cells, stromal cells, and the extracellular matrix is vital to support pro-tumor mechanisms …
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
D Xu, S Yin, Y Shu - npj Precision Oncology, 2024 - nature.com
Abstract Neurofibromatosis type 2 (NF2) is a tumor suppressor gene implicated in various
tumors, including mesothelioma, schwannomas, and meningioma. As a member of the ezrin …
tumors, including mesothelioma, schwannomas, and meningioma. As a member of the ezrin …